Ziegler, Carly G. K. Miao, Vincent N. Owings, Anna H. Navia, Andrew W. Tang, Ying Bromley, Joshua D. Lotfy, Peter Sloan, Meredith Laird, Hannah Williams, Haley B.
...
Published in
bioRxiv
Infection with SARS-CoV-2, the virus that causes COVID-19, can lead to severe lower respiratory illness including pneumonia and acute respiratory distress syndrome, which can result in profound morbidity and mortality. However, many infected individuals are either asymptomatic or have isolated upper respiratory symptoms, which suggests that the upp...
Tada, Takuya Dcosta, Belinda M. Zhou, Hao Vaill, Ada Kazmierski, Wes Landau, Nathaniel R.
Published in
bioRxiv
Monoclonal antibodies against the SARS-CoV-2 spike protein, notably, those developed by Regeneron Pharmaceuticals and Eli Lilly and Company have proven to provide protection against severe COVID-19. The emergence of SARS-CoV-2 variants with heavily mutated spike proteins raises the concern that the therapy could become less effective if any of the ...
Devkota, Kanchan Schapira, Matthieu Perveen, Sumera Yazdi, Aliakbar Khalili Li, Fengling Chau, Irene Ghiabi, Pegah Hajian, Taraneh Loppnau, Peter Bolotokova, Albina
...
Published in
bioRxiv
The COVID-19 pandemic has clearly brought the healthcare systems world-wide to a breaking point along with devastating socioeconomic consequences. The SARS-CoV-2 virus which causes the disease uses RNA capping to evade the human immune system. Non-structural protein (nsp) 14 is one of the 16 nsps in SARS-CoV-2 and catalyzes the methylation of the v...
Hutchison, James M. Capone, Ricardo Luu, Dustin D. Hadziselimovic, Arina Van Horn, Wade D. Sanders, Charles R.
Published in
bioRxiv
SARS-CoV-2 envelope protein (S2-E) is a conserved membrane protein that is essential to coronavirus assembly and budding. Here, we describe the recombinant expression and purification of S2-E into amphipol-class amphipathic polymer solutions. The physical properties of amphipols underpin their ability to solubilize and stabilize membrane proteins w...
Fischhoff, Ilya R. Castellanos, Adrian A. Rodrigues, João P.G.L.M. Varsani, Arvind Han, Barbara A.
Published in
bioRxiv
Spillback transmission from humans to animals, and secondary spillover from animal hosts back into humans, have now been documented for SARS-CoV-2. In addition to threatening animal health, virus variants arising from novel animal hosts have the potential to undermine global COVID-19 mitigation efforts. Numerous studies have therefore investigated ...
Dai, Yulin Wang, Junke Jeong, Hyun-Hwan Chen, Wenhao Jia, Peilin Zhao, Zhongming
Published in
bioRxiv
Background: The coronavirus disease 2019 (COVID-19) is an infectious disease that mainly affects the host respiratory system with ~80% asymptomatic or mild cases and ~5% severe cases. Recent genome-wide association studies (GWAS) have identified several genetic loci associated with the severe COVID-19 symptoms. Delineating the genetic variants and ...
Jangra, Sonia Landers, Jeffrey J. Rathnasinghe, Raveen O’Konek, Jessica J. Janczak, Katarzyna W. Cascalho, Marilia Kennedy, Andrew A. Tai, Andrew W. Baker, James R. Schotsaert, Michael
...
Published in
bioRxiv
Several promising vaccines for SARS-CoV-2 have received emergency use authorization in various countries and are being administered to the general population. However, many issues associated with the vaccines and the protection they provide remain unresolved, including the duration of conferred immunity, whether or not sterilizing immunity is impar...
Reiken, Steve Dridi, Haikel Sittenfeld, Leah Liu, Xiaoping Marks, Andrew R
Published in
bioRxiv
COVID-19, caused by SARS-CoV-2 involves multiple organs including cardiovascular, pulmonary and central nervous system. Understanding how SARS-CoV-2 infection afflicts diverse organ systems remains challenging 1,2 . Particularly vexing has been the problem posed by persistent organ dysfunction known as “long COVID,” which includes cognitive impairm...
Policard, Martine Jain, Sidharth Rego, Samantha Dakshanamurthy, Sivanesan
Published in
bioRxiv
The spread of SARS-CoV-2 and the increasing mortality rates of COVID-19 create an urgent need for treatments, which are currently lacking. Although vaccines have been approved by the FDA for emergency use in the U.S., patients will continue to require pharmacologic intervention to reduce morbidity and mortality as vaccine availability remains limit...
Philip, Asha A. Patton, John T.
Published in
bioRxiv
Rotavirus, a segmented double-stranded RNA virus, is a major cause of acute gastroenteritis in young children. The introduction of live oral rotavirus vaccines has reduced the incidence of rotavirus disease in many countries. To explore the possibility of establishing a combined rotavirus-SARS-CoV-2 vaccine, we generated recombinant (r)SA11 rotavir...